Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy

Japanese Journal of Infectious Diseases

Volumn 59, Issue 5, 2006, Pages 311-316

  Sun, Hsin Yun ^a   Chen, Mao Yuan ^a   Hsieh, Szu Min ^a   Sheng, Wang Huei ^a   Chang, Sui Yuan ^a,b   Hsiao, Chin Fu ^c,d   Hung, Chien Ching ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; MACROLIDE; RIFABUTIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CANDIDIASIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TAIWAN;

EID: 33750459369     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Detels, R., Tarwater, P., Phair, J.P., Margolick, J., Riddler, S.A., Munoz, A., Multicenter AIDS Cohort Study (2001): Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS, 15, 347-355.
2. Palella, F.J., Jr., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., Aschman, D.J. and Holmberg, S.D. (1998): Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med., 338, 853-860.
3. Kaplan, J.E., Hanson, D., Dworkin, M.S., Frederick, T., Bertolli, J., Lindegren, M.L., Holmberg, S. and Jones, J.L. (2000): Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin. Infect. Dis., 30, S5-14.
4. Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d'Arminio Monforte, A., Knysz, B., Dietrich, M., Phillips, A.N., Lundgren, J.D., EuroSIDA Study Group (2003): Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet, 362, 22-29.
5. Joint United Nations Programme on HIV/AIDS and World Health Organization (2005): AIDS epidemic updates, December 2005. UNAIDS/WHO, Geneva.
6. Bonnet, F., Lewden, C., May, T., Heripret, L., Jougla, E., Bevilacqua, S., Costagliola, D., Salmon, D., Chene, G., Morlat, P., Mortalite 2000 Study Group (2005): Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand. J. Infect. Dis., 37, 482-487.
7. Nunez, M., Asencio, R., Valencia, M.E., Leal, M., Gonzalez-Lahoz, J. and Soriano, V. (2003): Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses, 19, 363-368.
8. Dore, G.J., Li, Y., McDonald, A., Ree, H., Kaldor, J.M., National HIV Surveillance Committee (2002): Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J. Acquir. Immune Defic. Syndr., 29, 388-395.
9. Forrest, D.M., Seminari, E., Hogg, R.S., Yip, B., Raboud, J., Lawson, L., Phillips, P., Schechter, M.T., O'Shaughnessy, M.V. and Montaner, J.S. (1998): The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clin. Infect. Dis., 27, 1379-1385.
10. Mocroft, A., Katlama, C., Johnson, A.M., Pradier, C., Antunes, F., Mulcahy, F., Chiesi, A., Phillips, A.N., Kirk, O. and Lundgren, J.D. (2000): AIDS across Europe, 1994-98: the EuroSIDA study. Lancet, 356, 291-296.
11. Hung, C.C., Chen, M.Y., Hsieh, S.M., Sheng, W.H. and Chang, S.C. (2000): Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J. Acquir. Immune Defic. Syndr., 24, 378-385.
12. Wong, K.H., Chan, K.C. and Lee, S.S. (2004): Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin. Infect. Dis., 39, 853-860.
13. Chan, K.C., Wong, K.H. and Lee, S.S. (2006): Decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med., 7, 186-192.
14. Hung, C.C., Hsiao, C.F., Chen, M.Y., Hsieh, S.M., Chang, S.Y., Sheng, W.H., Sun, H.Y. and Chang, S.C. (2006): Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn. J. Infect. Dis., 59, 222-228.
15. Masur, H., Kaplan, J.E., Holmes, K.K., U.S. Public Health Service, Infectious Diseases Society of America (2002): Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann. Intern. Med., 137, 435-478.
16. The Panel on Clinical Practice for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. May 4, 2006. Online at .
17. Supparatpinyo, K., Khamwan, C., Baosoung, V., Nelson, K.E. and Sirisanthana, T. (1994): Disseminated Penicillium marneffei infection in southeast Asia. Lancet, 344, 110-113.
18. Sun, H.Y., Chen, M.Y., Hsiao, C.F., Hsieh, S.M., Hung, C.C. and Chang, S.C. (2006): Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Clin. Microbiol. Infect., 12, 381-388.
19. Lawn, S.D., Bekker, L.G. and Miller, R.F. (2005): Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect. Dis., 5, 361-373.
20. Dybul, M., Bolan, R., Condoluci, D., Cox-Iyamu, R., Redfield, R., Hallahan, C.W., Folino, M., Sathasivam, K., Weisberg, M., Andrews, M., Hidalgo, B., Vasquez, J. and Fauci, A.S. (2002): Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J. Infect. Dis., 185, 1818-1821.
21. Klein, D., Hurley, L.B., Merrill, D., Quesenberry, C.P., Jr., Consortium for HIV/AIDS Interregional Research (2003): Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J. Acquir. Immune Defic. Syndr., 32, 143-152.
22. Lohse, N., Hansen, A.B., Jensen-Fangel, S., Kronborg, G., Kvinesdal, B., Pedersen, C., Larsen, C.S., Moller, A., Willumsen, L. and Obel, N. (2005): Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand. J. Infect. Dis., 37, 338-343.
23. Perbost, I., Malafronte, B., Pradier, C., Santo, L.D., Dunais, B., Counillon, E., Vinti, H., Enel, P., Fuzibet, J.G., Cassuto, J.P. and Dellamonica, P. (2005): In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med., 6, 232-239.
24. Center for Disease Control (2001): Tuberculosis Annual Report 2001. Center for Disease Control, Department of Health, Republic of China, Taipei (in Chinese).
25. Sonnenberg, P., Glynn, J.R., Fielding, K., Murray, J., Godfrey-Faussett, P. and Shearer, S. (2005): How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J. Infect. Dis., 191, 150-158.
26. Hung, C.C. and Chang, S.C. (2004): Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J. Antimicrob. Chemother., 54, 849-853.
27. DeSimone, J.A., Pomerantz, R.J. and Babinchak, T.J. (2000): Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann. Intern. Med., 133, 447-454.
28. Hirsch, H.H., Kaufmann, G., Sendi, P. and Battegay, M. (2004): Immune reconstitution in HIV-infected patients. Clin. Infect. Dis., 38, 1159-1166.